Kraematon Investment Advisors Inc. bought a new position in Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 37,750 shares of the company’s stock, valued at approximately $1,021,000. Kraematon Investment Advisors Inc. owned approximately 1.76% of Innovator IBD 50 ETF at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of FFTY. NewEdge Advisors LLC bought a new stake in Innovator IBD 50 ETF during the 1st quarter valued at about $306,000. Bank of America Corp DE lifted its stake in shares of Innovator IBD 50 ETF by 307.2% in the second quarter. Bank of America Corp DE now owns 12,448 shares of the company’s stock worth $404,000 after buying an additional 9,391 shares in the last quarter. JPMorgan Chase & Co. bought a new stake in shares of Innovator IBD 50 ETF during the third quarter valued at approximately $478,000. BNP Paribas Financial Markets bought a new stake in shares of Innovator IBD 50 ETF during the third quarter valued at approximately $1,494,000. Finally, Prosperity Wealth Management Inc. bought a new stake in shares of Innovator IBD 50 ETF during the third quarter valued at approximately $637,000.
Innovator IBD 50 ETF Stock Down 0.7%
Shares of NYSEARCA FFTY opened at $36.28 on Friday. The firm has a market cap of $78.00 million, a P/E ratio of 30.34 and a beta of 1.45. Innovator IBD 50 ETF has a twelve month low of $31.61 and a twelve month high of $44.08. The company has a 50 day moving average of $38.13 and a 200 day moving average of $38.40.
Innovator IBD 50 ETF Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
Featured Stories
- Five stocks we like better than Innovator IBD 50 ETF
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Want to see what other hedge funds are holding FFTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innovator IBD 50 ETF (NYSEARCA:FFTY – Free Report).
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
